Delivery Order SPE2DB20D3101-SPE2DB23FQZA2
- Not listed
- This federal contract award is for the delivery of NARCAN 4 MG NASAL SPRAY 2S, a critical medication used to treat opioid overdose, to the Defense Logistics Agency (DLA). The $7,940.14 delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on May 10, 2023, with a completion date of May 11, 2023. AmerisourceBergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which holds a substantial Indefinite Delivery Contract (IDC) valued at up to...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of NARCAN 4 MG NASAL SPRAY 2S. The $2,354.53 firm-fixed-price contract has an ultimate completion date of January 25, 2023. Amerisourcebergen, a major pharmaceutical distributor, holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and...
- This federal contract award to AmerisourceBergen Drug Corp (a subsidiary of Cencora, Inc.) is for the delivery of NARCAN 4 MG NASAL SPRAY 2S, a critical medication used to treat opioid overdoses. The $2,772.75 firm-fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency within the Department of Defense. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which serves as the...
- This federal contract award is for the delivery of NARCAN 4 MG NASAL SPRAY 2S, a critical emergency medication used to treat opioid overdoses, to the Defense Logistics Agency (DLA). The contract, valued at $2,271.68, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a completion date of June 16, 2023 and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp is a subsidiary of the parent company...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $1,192.67 for 4,559,700,837 units of NARCAN 4 MG NASAL SPRAY 2S. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD), and has an ultimate completion date of January 25, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up...
- This federal contract award is a delivery order (SPE2DB23FP76X) issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of NARCAN 4 MG NASAL SPRAY 2S, a critical medication used for opioid overdose reversal. The contract has a firm fixed price of $8,758.69 and a completion date of August 21, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora,...
- This federal contract award is for the delivery of NARCAN 4 MG NASAL SPRAY 2S, a critical opioid overdose reversal medication, to the Defense Logistics Agency (DLA). The $1,459.58 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on April 30, 2024, with a completion date of May 1, 2024. This award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of NARCAN 4 MG NASAL SPRAY 2S, a critical opioid overdose reversal medication, with a ceiling value of $2,482.44 and a completion date of February 29, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., also known as Amerisourcebergen. The contract is a Delivery Order...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,449.12 firm fixed-price delivery order is for the supply of NARCAN 4 MG NASAL SPRAY 2S, a critical medication used to treat opioid overdoses. The contract has an ultimate completion date of December 20, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award is for the delivery of NARCAN 4 MG NASAL SPRAY 2S, a critical opioid overdose reversal medication, to the Defense Logistics Agency (DLA). The $3,896.53 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on September 7, 2023 with a completion date of September 8, 2023. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., a for-profit organization that serves as a key supplier of pharmaceutical...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB23FQZA2Delivery Order
This federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp., a subsidiary of Cencora, Inc., is for the delivery of NARCAN 4 MG NASAL SPRAY 2S, a critical opioid overdose reversal medication. The $4,593.74 firm-fixed-price delivery order has a completion date of January 5, 2023. This contract is not designated as a set-aside and was awarded through full and open competition. AmerisourceBergen, a major pharmaceutical distributor, holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical commodities. These contract vehicles enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.6k | 1/4/23 |